PROVIDER PROFILE · NPI 1619946753

Li LiuMD

PRACTICECANCER THERAPY MEDICAL GROUP INCSee all providers at this practice →

Radiation OncologyFresno, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

766

Unique beneficiaries

—

Total services

4,215

Distinct HCPCS

Medicare payment

$764K

Peer benchmark

Total Medicare services vs. 496 Radiation Oncology providers in CA — top quintile (cohort median 1,716).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$1K

Distinct drugs

Brand share

22.4%

Top prescribed drugs

Tamsulosin Hcl66 claims

Silver Sulfadiazine19 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$120

Payment records

By payment type

Food and Beverage$120

Top paying entities

Food and Beverage$120

REFERRAL NETWORK

Where Li Liu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	50	367
SAINT AGNES MEDICAL CENTER	48	299
Kathleen Behr Dermatology · Fresno, CA	39	166
PERKINS, CHRISTOPHER	30	549
John Julian Urology · Fresno, CA	16	93
Ucsf Dermatopathology Service Clinical Laboratory · San Francisco, CA	15	42
Yuk-Yuen Leung Urology · Fresno, CA	13	128
FRESNO COMMUNITY HOSPITAL AND MEDICAL CENTER	12	79

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history